Abstract
Introduction
Clostridium difficile infection (CDI) is the major cause of healthcare associated diarrhoea [1] . The pathogenic mechanism is toxigenic, the virulence factors being enterotoxin A and cytotoxin B. In the last years CDI has shown increased incidence and severity, becoming a serious public health issue in countries with a large consumption of broad spectrum antimicrobials, especially fluoroquinolones, 2 nd to 4 th generation cephalosporins and carbapenems [1] [2] [3] . This change in CDI epidemiology was the result of the global spread of the hypervirulent strain NAP1/027/BI, derived from a classical ribotype 027 after fluoroquinolones resistance acquisition; Stadler et al. identified at least five genetic region changes in ribotype 027 compared with isolates from 1984 [4] . The higher epidemic risk of the hypervirulent ribotype 027 seems to be the result of an increased production of toxins A and B, the synthesis of a supplemental binary toxin, and a higher capacity of spore production [2] . Accurate diagnosis of CDI is needed both for patient management and initiation of adequate infection control measures. A long-lasting CDI epidemic in a medical facility and the detection of binary toxin positive isolates strongly suggest the involvement of C. difficile ribotype 027, since other C. difficile binary toxin-positive ribotypes, like 078 or 244, are much less frequently involved in human disease [3, 5] . In the first months of 2011 the number of CDI cases in Bucharest increased sharply. Although C. difficile ribotyping was not performed at that moment, the strains were collected and tested several months later in reference laboratories from Leiden, Netherlands and Vienna, Austria, thus confirming the change in the epidemiology of CDI and the increased proportion of ribotype 027 in Romania [6] .
The purpose of the present study was to evaluate the utility of a commercial assay using PCR coupled with electrospray ionization mass spectrometry (ESI-MS) for the detection of Clostridium difficile virulence markers in isolates from patients with CDI.
Methods

Bacterial isolates
The study analyzed 45 non-duplicative isolates of Clostridium difficile from patients with CDI admitted from July to December 2011 in the National Institute for Infectious Diseases (NIID), a tertiary level hospital from Bucharest, Romania. Forty-three patients with a clinical suspicion of CDI were transferred to NIID from several hospitals located in the Bucharest area; the other two patients were documented hospital associated cases, being diagnosed shortly after a previous NIID hospitalization. An informed consent was obtained from each patient. All 45 isolates were stored at −80 °C in cryobank tubes until DNA testing and were subcultured on Columbia blood agar plates (bioMérieux, Marcy l'Etoile, France) before testing.
Reference methods for identification of C. difficile virulence markers All 45 isolates were tested in June 2012 at the Austrian Reference Centre for Clostridium difficile (AGES, Vienna, Austria). A previously described protocol using PCR/ capillary gel electrophoresis was used for PCR ribotyping (RT) [7] . A PCR based toxin typing was performed, as previously described, for toxin A [8] , toxin B [9, 10] and tcdC deletion [12] . These results were considered as reference.
PCR/ ESI -MS protocol for C. difficile
All 45 isolates were tested in August 2012 at the National Institute for Infectious Diseases (NIID), Bucharest, Romania. Nucleic acid extraction from isolate suspension was performed on the EasyMag instrument (Biomerieux, Marcy l`Etoile, France) using the specific B protocol, according with the manufacturer's recommendations, the extracted DNA being eluted in a 40 µl volume of elution buffer.
For polymerase chain reaction (PCR) and subsequent mass spectrometry we used the C. difficile Typing and Virulence Assay (Abbott Molecular, Des Plains, USA). This commercial assay is based on eight PCR reactions performed simultaneously, with the following protocol: initial denaturation 95ºC, 10 minutes, then 8 cycles of 95ºC for 30 seconds, 48ºC for 30 seconds, 72ºC for 30 seconds, followed by 37 cycles of 95ºC for 15 seconds, 56ºC for 20 seconds, 72ºC for 20 seconds, and a final step of 72ºC for 2 minutes, 99ºC for 20 minutes. Two primer pairs target regions of tpi (triosephosphate isomerase gene), allowing Clostridium species identification, and other four primer pairs target genes encoding C. difficile virulence factors: binary toxin alpha and beta subunits (cdtA and cdtB, respectively), enterotoxin A (tcdA) and cytotoxin B (tcdB). The assay describes two polymorphism variants of the tcdB gene: wild type and mutant. The last two PCR reactions are designed to detect deletions in the tcdC gene: a single base pair deletion at position 117, responsible for a frameshift that create a stop codon at position 196 [13] or other deletions [14] .
PCR products were analyzed by electrospray ionization -time of flight mass spectrometry using the PLEX-ID analyzer (Abbott Molecular, Des Plaines, IL, USA). This instrument automatically measures the molecular weight of each PCR product, calculates the base composition of the products and compares these data with information from an internal database, using an integrated software.
Results
Characterization of C. difficile isolates using PCR/CGE
All but one of the 45 C. difficile isolates produced toxins. Following PCR RT 433 an isolate was found to lack the genes for toxin A, toxin B and binary toxin. All 44 toxigenic strains harboured toxin A and toxin B and 33 (75%) of these isolates were also positive for both binary toxin genes.
Ribotype 027 was the dominant ribotype, accounting for 33 (75%) of the 44 toxigenic strains. The remaining 12 isolates were ribotype 018 (n = 6), 012 (n = 2), and one isolate each of: 081, 433, 500 and PR03055 (new ribotype). The distribution of ribotypes among the 45 isolates and the characterization of the virulence factors of these isolates are presented in table I.
Characterisation of the 45 C. difficile isolates using PCR/ESI-MS
All but one of the 45 isolates tested with PCR / ESI-MS were tcdA and tcdB positive; one iso-late of PCR-RT 433 was identified as only tcdB positive. The binary toxin coding genes, cdtA and cdtB, were detected in 35 isolates: 33 of them belonged to RT 027 and two of them belonged to RT 018 and 500. In other two isolates of RT 012 and PRO3035, the assay detected only the cdtA gene; these 37 possible producing binary toxin isolates represent 82.2% of the C. difficile strains, CI95% (68.7%; 90.7%). In 34 of these 37 cases (91.9%) this method identified also an 18 bp and respectively 117 bp tcdC deletion (table II). All isolates with tcdC deletions had the tcdB variant and only one of the other 11 isolates had this tcdB variant: 100% versus 9.1%, p < 0.00001.
In all but five isolates the PCR/ ESI-MS showed similar virulence marker profiles compared to the reference methods, with an overall complete concordance of 88.9% (CI95% 76.5%-95.2%). The concordance was good for each of the virulence markers: 100% (CI 95% 92.1-100%) for toxin A gene, 97.8% (CI95% 88.4-99.6%) for toxin B gene, 91.1% (CI 95% 79.3 -96.5) for binary toxin subunit A gene and 95.6% (CI 95% 85.2 -98.8) for binary toxin subunit B gene (table III) . In ribotype 027 strains this concordance was 100% for each marker.
In four strains, belonging to ribotypes 012, 018, 500 and PRO3055, the binary toxin subunit A gene was detected with PCR/ESI-MS only.
The association between the binary toxin and the 18 bp deletion in tcdC gene, detected with PCR/ESI-MS, identified ribotype 027 strains with a positive predictive value of 91.6% and a negative predictive value of 100%. 
tcdA = enterotoxin A gene, tcdB = cytotoxin B gene; cdtA = binary toxin alpha subunit gene; cdtB = binary toxin beta subunit gene; tcdC = putative negative regulator of the production of toxin A and B; PRO3035 = new RT. wt -wild type m -mutant
Discussions
Broad-range PCR coupled with electrospray ionization mass-spectrometry was developed both for clinical diagnosis and epidemiological surveillance, being able to provide a rapid identification of multiple bacterial, fungal and viral pathogens from clinical samples during outbreaks [15, 16] . The present study showed that PCR/ESI-MS might be a valid method for C. difficile identification and detection of virulence markers, with a valuable role for the identification of emerging hypervirulent strains. However, other aspects, like costs and complexity of the equipment, may impact the clinical utility of this method. At this stage it is difficult to perform a clinical cost-benefit analysis since PCR-ESI-MS and PCR-CGE are research techniques used mainly for epidemiological purposes, with costs that vary from one setting to another.
The recent emergence of CDI with ribotype 027 was described in several areas where infection control procedures failed to contain the spread of this ribotype. In contrast, countries with sustained and efficient infection control interventions were able to reduce the prevalence of ribotype 027 infections. United Kingdom is an example of such successful actions, resulting in a decrease of ribotype 027 prevalence from 55% to 21% in five years [17] . In Bucharest area the high proportion of CDI with ribotype 027 was first suggested by the sharp increase of incidence and severity of CDI admitted in NIID starting with 2011: a seven fold increase of CDI cases in 2011 compared to the previous year and a 10% lethality compared with no fatalities in 2010 [6] .
The dominance of ribotype 027 strains described in the present study is most probably not the result of a single hospital outbreak, because tcdA = enterotoxin A gene, tcdB = cytotoxin B gene; cdtA = binary toxin alpha subunit gene; cdtB = binary toxin beta subunit gene; tcdC = putative negative regulator of the production of toxin A and B; del = deletion the patients admitted in NIID, an infectious diseases tertiary level hospital, were transferred from virtually all other hospitals in Bucharest and the surrounding area. The detection of ribotype 027 described in the present study is very high compared to data from other countries and is probably related to the state of epidemic CDI in this region. Other studies revealed that 027 remained during the following years the dominant ribotype in Bucharest and in many other Romanian regions [18] . In one isolate (RT 433) only toxin B gene was detected, the gene for toxin A being undetectable. The result for toxin B gene was not confirmed by the reference method. Although the virulence of toxA-toxB + C. difficile strains was not fully accepted, more recent data confirm their involvement in CDI pathogenesis, some studies suggesting an even higher virulence compared to the toxA+toxB+ strains [19] . This particular toxigenic C. difficile is present in variable proportions in different statistics and is not correlated with a specific ribotype.
A limitation of our study was the small number of isolates analyzed, mainly for non-027 ribotypes. Although unexpectedly high, the increased prevalence of the 027 strains in the present study is concordant with the prevalence described in a larger study performed in 11 Romanian hospitals [18] and therefore is not likely to be considered, in our opinion, the result of sampling bias.
Conclusions
The present study demonstrated that PCR coupled with ESI-MS might be a valid method for detection of C. difficile virulence markers.
The characteristics of the isolates tested with this method confirm the emergence of C. difficile ribotype 027 in Bucharest area in 2011.
